Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × relugolix × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 6 Prostate Adenocarcinoma 1 Neoplasm Metastasis 1

Interventions

Specimen Handling 32 Biopsy 28 Magnetic Resonance Spectroscopy 24 pembrolizumab 23 Paclitaxel 15 Carboplatin 15 Nivolumab 12 Gemcitabine 12 Taxes 9 Cisplatin 9 trastuzumab deruxtecan 8 abemaciclib 7 Pemetrexed 7 Ipilimumab 7 130-nm albumin-bound paclitaxel 7 X-Rays 6 Radiosurgery 6 Irinotecan 6 Cyclophosphamide 6 Cetuximab 6 Trastuzumab 5 Fulvestrant 5 Fluorouracil 5 Drug Therapy 5 Bevacizumab 5 Albumin-Bound Paclitaxel 5 olaparib 4 fludarabine 4 durvalumab 4 Oxaliplatin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04787744 2026-04-08

VA STARPORT

VA Office of Research and Development

Phase 2/3 Recruiting

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡